$GlycoMimetics (GLYC.US)$ After half a year of receiving, there was finally some movement, and everyone has returned.

$Maxeon Solar Technologies (MAXN.US)$ an analyst from Mizuho Securities, maintained the Hold rating on Maxeon Solar Technologies ( – ). The associated price target was lowered to $0.20.

$Renalytix (RNLX.US)$ H.C. Wainwright analyst Yi Chen maintains a buy rating for renalytix (RNLX.US), with a target price of $3.
According to TipRanks data, the analyst has a total success rate of 24.7% in the past year, with a total average return on investment of -24.6%.

$Renalytix (RNLX.US)$ show was over. Wait for the next round